BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 16083423)

  • 1. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
    Vitari AC; Deak M; Morrice NA; Alessi DR
    Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
    Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
    Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
    Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
    Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
    Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
    J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions with WNK (with no lysine) family members regulate oxidative stress response 1 and ion co-transporter activity.
    Sengupta S; Tu SW; Wedin K; Earnest S; Stippec S; Luby-Phelps K; Cobb MH
    J Biol Chem; 2012 Nov; 287(45):37868-79. PubMed ID: 22989884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
    Ponce-Coria J; Markadieu N; Austin TM; Flammang L; Rios K; Welling PA; Delpire E
    J Biol Chem; 2014 Jun; 289(25):17680-8. PubMed ID: 24811174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
    Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNK lies upstream of kinases involved in regulation of ion transporters.
    Gamba G
    Biochem J; 2005 Oct; 391(Pt 1):e1-3. PubMed ID: 16173916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress.
    Zagórska A; Pozo-Guisado E; Boudeau J; Vitari AC; Rafiqi FH; Thastrup J; Deak M; Campbell DG; Morrice NA; Prescott AR; Alessi DR
    J Cell Biol; 2007 Jan; 176(1):89-100. PubMed ID: 17190791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.
    Richardson C; Rafiqi FH; Karlsson HK; Moleleki N; Vandewalle A; Campbell DG; Morrice NA; Alessi DR
    J Cell Sci; 2008 Mar; 121(Pt 5):675-84. PubMed ID: 18270262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
    Argaiz ER; Chavez-Canales M; Ostrosky-Frid M; Rodríguez-Gama A; Vázquez N; Gonzalez-Rodriguez X; Garcia-Valdes J; Hadchouel J; Ellison D; Gamba G
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F734-F745. PubMed ID: 29846116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4.
    Rafael C; Soukaseum C; Baudrie V; Frère P; Hadchouel J
    Sci Rep; 2018 Feb; 8(1):3249. PubMed ID: 29459793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of WNK1 knockout cell lines by CRISPR/Cas-mediated genome editing.
    Roy A; Goodman JH; Begum G; Donnelly BF; Pittman G; Weinman EJ; Sun D; Subramanya AR
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F366-76. PubMed ID: 25477473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells.
    Anselmo AN; Earnest S; Chen W; Juang YC; Kim SC; Zhao Y; Cobb MH
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10883-8. PubMed ID: 16832045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
    Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
    PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.
    de Los Heros P; Alessi DR; Gourlay R; Campbell DG; Deak M; Macartney TJ; Kahle KT; Zhang J
    Biochem J; 2014 Mar; 458(3):559-73. PubMed ID: 24393035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.
    Gao JL; Peng K; Shen MW; Hou YH; Qian XB; Meng XW; Ji FH; Wang LN; Yang JP
    J Pain; 2019 Dec; 20(12):1416-1428. PubMed ID: 31085334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.